York Dermatology Center

Richmond Hill, Ontario L4C 9M7

1 studies enrolling now · 9 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Dermatitis, Atopic, Hidradenitis Suppurativa (HS), Moderate to Severe Plaque Psoriasis, Plaque Type Psoriasis, Psoriasis, Venous Leg Ulcer

Studies at this site

• Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 — Completed
• MSB11022 in Moderate to Severe Chronic Plaque Psoriasis — Completed
• Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis — Completed
• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• Dose-response Relationship Study of S42909 on Leg Ulcer Healing — Completed
• Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata — Completed
• A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis — Completed
• Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis — Completed